Biocartis named as a Technology Pioneer 2012 by the by the World Economic Forum. Technology Pioneers comprise 25 of the most innovative young companies from around the world, companies poised to have a critical impact on how business and society work.
"The Technology Pioneers program recognizes companies whose cutting-edge technologies are transforming business and society and we are very proud to have been selected by the judging panel. At Biocartis our vision is for people to have quick access to personalized medicine anywhere and anytime. We want to enhance the quality of life through better diagnosis and better treatments with modern diagnostics available in the widest possible variety of healthcare settings," said Rudi Pauwels, Biocartis' CEO.
Biocartis is a company that focuses on the development and commercialization of versatile and compact molecular diagnostic solutions that will make molecular diagnostic testing easier to perform in a wider range of healthcare settings. The Company was founded in 2007 by Dr. Rudi Pauwels (Co-founder of Tibotec, Virco and Galapagos Genomics), Prof. Philippe Renaud (Prof. at EPFL), and Nader Donzel (Co-founder of Scitec laboratory Automation).
At this moment the Company is developing two innovative systems that share a common user interface and design philosophy:
- A system for molecular diagnostics of nucleic acids (DNA/RNA) that is composed of an instrument, communication console and single use, disposable cartridges. This system can detect and quantify multiple DNA- or RNA-based biomarkers in a wide variety of patient sample types with truly minimal user intervention.
- A system built around disposable, microfluidic cartridges with digitally encoded micro carriers for the rapid and sensitive detection of a broad range and number of biomarkers. The first product from this technology will focus on protein-based biomarkers.
The ultimate goal is to carry out diagnostic tests rapidly and cost-effectively when and where key clinical decisions need to be made.
Biocartis SA is based at the EPFL's Innovation Square in Lausanne, Switzerland; its Belgian fully owned subsidiary in Mechelen and the Dutch subsidiary at the High Tech Campus in Eindhoven.
.
0Comments
Please login or sign up to comment.
Commenting guidelines